Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment
Objective: The standard dose of depot gonadotropin releasing hormone agonist (GnRHa) may be too much to prevent premature luteinizing hormone (LH) surge in controlled ovarian stimulation (COS). The purpose of this study was to find out the minimal effective dose of Leuplin depot to prevent premature...
Main Authors: | Heng-Ju Chen, Yu-Hung Lin, Mei-Zen Huang, Kok-Min Seow, Lee-Wen Huang, Bih-Chwen Hsieh, Chii-Ruey Tzeng, Jiann-Loung Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-04-01
|
Series: | Taiwanese Journal of Obstetrics & Gynecology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1028455916000346 |
Similar Items
-
Ganirelix and the prevention of premature luteinizing hormone surges
by: Bernadette Mannaerts, Ph.D.
Published: (2023-06-01) -
Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
by: Yun Wang, et al.
Published: (2018-08-01) -
Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF—How to Minimize Failure to Retrieve Oocytes
by: Mauro Cozzolino, et al.
Published: (2020-04-01) -
Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval
by: Tzu-Ching Kao, et al.
Published: (2023-01-01) -
Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
by: Qiuju Chen, et al.
Published: (2019-11-01)